Zydus Wellness
Stock Snapshot
Price Performance
Vista Outlook
Basis of our Recommendation
Zydus Wellness is navigating a complex landscape characterized by both opportunities and challenges. Management's focus on premiumization and science-led innovation is pivotal, particularly as the company seeks to leverage its parent, Zydus Lifesciences, for R&D capabilities. Despite recent seasonal headwinds affecting core brands like Glucon-D and Nycil, Zydus has shown resilience through strong performance in its Skin and Hair Care and Food & Nutrition segments. This aligns with Vista's forecast of moderating revenue growth but improving margins, as the company capitalizes on strategic price hikes and a diversified product pipeline. The FMCG sector's overall expansion, driven by e-commerce and digital strategies, supports Zydus's long-term growth potential. However, rising crude oil prices and competitive pricing pressures pose significant risks. Over the next 12-24 months, Zydus's key opportunities lie in international expansion and innovation within its wellness portfolio, while watchpoints include weather sensitivity and integration challenges from recent acquisitions. Overall, Vista's outlook reflects cautious optimism, with a premium valuation indicating limited upside potential in the near term
Why We Like This Stock
- Management's strategic focus on premiumization and innovation is expected to drive sustainable growth
- Strong performance in non-seasonal segments demonstrates resilience amid seasonal challenges
- International expansion and a diversified product pipeline present significant growth opportunities
Things To Watch Out For
- Rising crude oil prices and competitive pricing pressures may impact profit margins
- Seasonal demand fluctuations pose risks to core product performance
- Integration challenges from recent acquisitions could hinder operational efficiency
Key Parameters
Financial Snapshot
View Technicals Analysis →| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 2,328 | 2,709 | 3,961 | 4,462 | 5,098 |
| Profit Before Tax (Cr.) | 272 | 344 | 271 | 282 | 349 |
| PBT Margin | 11.7% | 12.7% | 6.8% | 6.3% | 6.8% |
| Net Profit (Cr.) | 272 | 344 | 235 | 246 | 304 |
| Earnings Per Share | 8.6 | 10.8 | 7.4 | 7.7 | 9.6 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| Motilal Oswal | ▲ Buy | 665 | 06-Aug-2026 |
| ICICI Securities | ▲ Buy | 630 | 05-Aug-2026 |
| Mirae Asset | ▲ Buy | 552 | 14-May-2026 |
Company Overview
Show Company Profile
Zydus Wellness Limited engages in the development, production, marketing, and distribution of health and wellness products in Asia, the Middle East, Africa, the Oceania, Europe, and North America. It provides glucose powder under the Glucon-D brand; sugar substitute products under the Sugar Free Gold+, Sugar Free Natura, Sugar Free Green, and I'm lite brands; Milk-based nutrition drink products under the Complan brand; table spreads under the Nutralite brand; skin cleansing products under the Everyuth brand; hair color products under the Cuticolor brand; heat powder under the Nycil brand; and healthy eating products, such as snack bars, protein bars, breakfast cookies, and protein chips under the RiteBite brand. The company also offers plant-based supplements, vitamins and minerals, collagens, omegas, probiotics, and micronutrients for adults under the WeightWorld brand; health and wellness products, including multivitamin and vitamin D3 gummies, mushroom-based supplements, and other superfood supplements under the MaxMedix brand; and food supplements for dogs and cats under the Animigo brand. The company was formerly known as Carnation Nutra-Analogue Foods Limited and changed its name to Zydus Wellness Limited in January 2009. The company was founded in 1988 and is headquartered in Ahmedabad, India. Zydus Wellness Limited operates as a subsidiary of Zydus Lifesciences Limited.